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termination. CONCLUSIONS: Clinical trial learning curves have significant impli-
cations for outcomes research accuracy, patient safety, and overall trial success.
Clinical trial simulation may provide a broadly applicable methodology for ad-
dressing several factors associated with clinical trial learning curve effects and for
improving the accuracy of clinical trial outcomes.
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OBJECTIVES: Recent developments in the United States (US) health care reform
and funding for comparative effectiveness research suggest that use of electronic
medical records (EMR) in outcomes research may increase over time. EMR can be
particularly useful when outcomes are not well-defined with diagnosis or proce-
dures codes or when clinical data are needed. The objective of this study was to
review trends in the use of EMR during the past decade. METHODS: A review of
published literature was conducted in PubMed for years 2001 through 2010 to iden-
tify outcomes studies in the US that used EMR. Internal quality assurance studies
and validation studies that used EMR were excluded. The number of studies, set-
ting of care, patient population,whether the studywas comparative, and anynoted
limitationswere examined. RESULTS:A total of 58 EMR-based, outcomes studies in
the USwere identified over the past decade; increasing from 3 in 2001 to 12 in 2010.
The majority of studies included outpatient EMR. Studies included a variety of
patient populations with over one-third in cardiovascular disease, psychiatric dis-
ease, and diabetes combined. The percent of studies that were comparative ranged
from 0% in 2001 to 45% in 2010. Measures of effectiveness varied widely and in-
cluded lab values, clinical measures, and health-related quality-of-life outcomes.
Some noted limitations on the use of EMR data in outcomes research included lack
of representativeness of all care delivered across practice settings, lack of general-
izability and standardization, and reliance on health care provider reporting.
CONCLUSIONS: Although the use of EMR in outcomes research has increased
slowly in the past decade, the proportion of comparative studies using EMR has
increased over time. As the industry works to standardize EMR andmore advanced
outcomes are collected in EMR systems, EMR data may play a larger role in com-
parative effectiveness research.
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THE OUTLOOK OF LARGE SIMPLE TRIALS FOR COMPARATIVE EFFECTIVENESS
RESEARCH: AN APPLICATION OF THE PRECIS FRAMEWORK
Vincent L
Quintiles Global Consulting, Hawthorne, NY, USA
OBJECTIVES: In recent years, comparative effectiveness research (CER) has gained
increasing interest and investment across major life science and health policy
stakeholder groups: regulators, biopharmaceuticals, physicians, patients, and pay-
ers. Onemethod, large simple trial (LST), a hybrid of observational cohort study and
randomized control trial (RCT), is designed for large numbers of patients in post-
approval research and is a choice study design for comparing the relative strengths
and weaknesses of medical interventions. The objective of this study was to eval-
uate the current landscape of LSTs to capture key themes in the future outlook of
CER. METHODS: A structured abstract review and funnel analysis was conducted
using data available through ClinicalTrials.gov. Using the search terms, “phase IV”,
“post-marketing”, “randomized”, and “multi-centered”, 2230 clinical trials were
filtered with restricted parameters for number of patients (n1000), evidence of
blinding, stated objective of comparative effectiveness, and date of trial initiation.
RESULTS: To gain a perspective on current and future outlook, only trials initiated
between 2009 and 2010 (n10) were assessed in this phase of study. Using the
Pragmatic Explanatory Continuum Indicator Summary (PRECIS) framework origi-
nally developed for pragmatic trials, the analysis revealed an important theme.
When applying key domain criteria – practitioner expertise, treatment flexibility,
eligibility criteria, health outcomes, study duration, intent-to-treat (ITT), and pri-
mary outcome analysis, as defined by the PRECIS framework – less than 50% of the
LST CER trials were designed to measure effectiveness, as opposed to efficacy.
CONCLUSIONS: According to findings, there has been an uptake on the use of LSTs
in investigating the relative effectiveness of interventions. However, considering
the increase in governmental pressure to reduce healthcare spending by improving
quality of treatment; it is important that these LSTs are conducted to truly capture
effectiveness. For that reason, there is need for further research to extract and
develop new frameworks for evaluation.
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OBJECTIVES: To investigate the state of health economic research in Russia avail-
able in the English language by describing the number and characteristics of the
articles, and assessing the quality of these articles.METHODS: The study assessed
the state of health economics and pharmacoeconomics research in Russia. We
conducted a literature search to identify health economics articles pertaining to
Russia. Each article in the final sample was scored by two reviewers independently
using the data-collection form designed for the study. RESULTS: In total, 16 studies
investigating a wide variety of diseases were included in the study. These articles
were published in 15 different journals all based outside of Russia between 1994
and 2009. On average, each article was written by seven authors. Most first authors
had medical/clinical training and resided in the USA (n  8) at the time of publica-
tion of the study. Based on a scale of 1–10,with 10 indicating the highest quality, the
mean quality score for all studies was 8.09 (SD  1.29) and 25% of the articles were
of fair quality (score 5–7). The quality of articles was statistically significantly re-
lated (P  0.05) to the primary health intervention (pharmaceuticals  non-phar-
maceuticals) and primary training of the first author (medical  non-medical).
CONCLUSIONS: The conduct of health economics and pharmacoeconomics research
in Russia in the English language is limited and, on average, the published articles
were of good quality. However, about one-quarter of published articles were of fair
quality. More health economics research in English is warranted in Russia.
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CHARACTERISTICS OF HOMELESS INDIVIDUALS USING INPATIENT AND
EMERGENCY DEPARTMENT SERVICES
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OBJECTIVES: This study compares the patient characteristics, insurance coverage,
disease prevalence, and utilization patterns of inpatient and emergency depart-
ment (ED) services between homeless and non-homeless people using a new data
source that has not been employed in existing studies.METHODS: A retrospective
data analysis was conducted to compare differences in patient characteristics,
insurance coverage, disease prevalence, and utilization patterns between home-
less and non-homeless individuals who visited a hospital or hospital-based emer-
gency department. For each service type, separate rates were created for homeless
and non-homeless populations and then compared. The Healthcare Cost and Uti-
lization Project (HCUP) State Inpatient Databases (SID) and State Emergency De-
partmentDatabases (SEDD) for 2008were used in the analysis. The SID employed in
this study include 15.9 million inpatient hospital discharges from community hos-
pitals in ten states – Arizona, California, Colorado, Florida, Georgia, Massachusetts,
Missouri, NewYork, Pennsylvania andWisconsin. 177,056 of these dischargeswere
homeless patients. The SEDD employed in this study include 23.7 million visits to
ED, where patients were treated and released, from seven states (i.e., Arizona,
Florida, Georgia, Massachusetts, Missouri, New York and Wisconsin). 49,595 of
these visits were homeless patients. RESULTS: The uninsured homeless (non-
homeless) patients were accountable for 28.1% (4.6%) of inpatient admissions and
42.85 (21%) of ED visits. Medicaid covered 48.2% of all inpatient discharges and
34.7% of all ED visits by homeless patients. 73.7% (50.6%) of homeless (non-home-
less) inpatient admissions came through EDs. Homeless patients with mental dis-
orders accounted for 22.4% of all homeless inpatient discharges and 49% of all
homeless ED visits. A majority of the mental disorder diagnosis in both settings of
care were alcohol-related disorders, mood disorders, and schizophrenia.
CONCLUSIONS: The profile of homeless and non-homeless patients differed sig-
nificantly by insurance status and by race in both the inpatient and emergency
department settings.
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OBJECTIVES: Health economies outside Western Europe are increasingly adopting
evidence-based decision-making, but implementation methods differ. Common-
alities in the approach taken in Turkey and Poland nevertheless illustrate the role
of a previously developed reimbursement process in the adoption of HTA. Insights
from this comparisonmay have implications for industry, government and private
reimbursement authorities worldwide. METHODS: Turkey and Poland were se-
lected for comparison due to their relatively recent adoption of HTA within an
established reimbursement system. A total of 18 stakeholderswere interviewed via
telephone interviews to understand current and future utilisation of HTA in reim-
bursement. The study evaluated the impact of the following decision-making do-
mains: clinical differentiation, prioritisation of unmet needs, price, and presenta-
tion requirements (e.g. budget impact analysis). A comparisonwas thenmade on a
rating scale devised to account for these influencing factors. RESULTS: In Turkey
the pharmacoeconomics unit of the Social Security Institute is responsible for
economic evaluation. However the Polish HTA body AHTAPol is more directly in-
volved in the HTA process. All 9 Polish respondents scored high on the influence of
HTA in access decisions while just 2 respondents in Turkey considered HTA to be
extremely influential in reimbursement. However, pricing decisions in both coun-
tries are based on international referencing to varying degrees. CONCLUSIONS:
Despite superficial similarities in the structure of their reimbursement systems,
HTA in Poland is more closely integrated with decision making than in Turkey. At
present HTA plays a formal role in the Turkish system but a negotiation-based
approach remains to customary channel for value arguments. However, the rapid
pace of change in the Turkish reimbursement system suggests the need for further
ongoing research.
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RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION
AMONG FUTURE PHARMACISTS
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OBJECTIVES: Trends in the use of herbalmedications continue to rise. Pharmacists
have an opportunity to provide consumers with evidence based information. This
study examined pharmacy student’s knowledge regarding herbal medication from
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courses and the associated outcomes towards attitude formation.METHODS: In a
cross-sectional prospectively designed study a survey was self-administered to
second, third and final year doctorate of pharmacy students at a University with
diverse student body. The questionnaire included four sections: attitude, educa-
tion, knowledge and demographic. Pre-validated instruments were used to mea-
sure attitude towards herbal medications using a five-point likert scale while
knowledge was measured using a true-false scale. Descriptive statistics were used
to summarize data and multiple logistic regression was conducted to assess the
effect of pharmacy student’s herbal medication knowledge towards attitude for-
mation while controlling for age, race, sex, year of study, work experience and
herbal medication related courses. RESULTS: Of 206 students, 159 completed the
survey (response rate of 77.18%). Mean age of participants was 26 (3.2) years with
65.41% female and 81.13% had previous pharmacy work experience. The average
score on the herbal knowledge was 9.281.80 (maximum score of 15). Students
with higher knowledge hadpositive attitude towards herbalmedications (OR1.26;
95% CI1.01-1.57). Students with work experience had positive attitude towards
herbal medications (OR2.93; 95% CI1.05-8.14). However, 81% students believed
that they did not have sufficient knowledge of herbal medications and 91% stu-
dents reported that they neededmore information. CONCLUSIONS:Higher knowl-
edge leads to a positive attitude towards herbal medications among pharmacy
students indicating that they may recommend such products to patients. Evaluat-
ing the role of such recommendations to improve patients health outcomes is the
direction for the future.
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OBJECTIVES: The well-being of caregivers of children with chronic conditions can
be influenced by several aspects of their child’s care and their complex healthcare
needs. The objective of this study is to examine well-being and experiences of
caregivers of children with different chronic condition.METHODS: The study was
cross-sectional and used responses of caregivers of 19,423 children (aged 6-17
years) from the National Survey of Children’s Health, 2007. We created a hierarchy
of chronic conditions to classify children from our analytic sample in 6 mutually
exclusive groups: Autism SpectrumDisorder (ASD), Developmental delay/Learning
disability, Attention deficit hyperactivity disorder/behavioral problems, Depres-
sion/anxiety, Speech/hearing/vision problems, and Diabetes/asthma.We assessed
caregiverwell-being in three dimensions: physical health,mental health, and emo-
tional stress. Healthcare experiences were measured in two domains: Access
(health insurance adequacy and consistency; and unmet healthcare needs), Qual-
ity (family-centered care-FCC, and effective care-coordination-ECC). All analyses
adjusted for the for the complex survey design, to derive national estimates. Chi-
square tests, logistic and multinomial logistic regressions were performed in SAS
9.2. RESULTS: Physical health of caregivers was negatively affected by access to
care (unmet needs) and healthcare quality (lack of FCC). And poor mental health
was negatively associated with lack of ECC. As compared to caregivers of children
with asthma/diabetes, a higher percentage of caregivers with ASD children re-
ported poor physical health (26.6% vs 12.7%), poor mental health, and high emo-
tional stress (26.5% vs 2.1%). CONCLUSIONS: Child’s ASD places significant burden
on the caregiverwell-being, compared to other conditions. In addition to the type of
child’s disability and chronic condition, caregivers were at high risk for poor phys-
ical health and high emotional distress due to unmet needs for children’s health
and lower levels of the child’s healthcare quality.
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OBJECTIVES: With very few restrictions on choosing physicians under National
Health Insurance (NHI) program in Taiwan, patients could visit outpatient depart-
ments (OPD) in a tertiary medical facility to seek the primary care other than
secondary care. This study was to examine the impact of Integrated Medical Care
(IMC) services in China Medial University Hospital (CMUH), a 2000-bed medical
center, in Taiwan. METHODS: Those patients who made more than 50% of their
total OPD visits in Taiwan toward CMUH during January 2008 to June 2009 (baseline
period) were recognized as CMUH loyal patients. They were invited to utilize the
offered pluralistic IMC services, including integrated, geriatric and pharmaceutical
care clinics, in addition to usual primary and specialty clinics, during December
2009 toDecember 2010 (implementation period). Thosewhoused to visit one or two
specialists in CMUH were of the most interest. The computerized reminding and
medication utilization evaluation (MUE) systems were established to facilitate the
cooperative physician-clinical pharmacist medication therapy management
model. The medical and medication-related issues were reviewed by prescribers,
clinical pharmacists and the clinical MUE team as needed. The differences of med-
ical expenditure reimbursed by NHI, OPD visits, number of prescribed medication
(Rx) and emergency department (ED) visits in CMUH during baseline and imple-
mentation periods were examined. RESULTS: Of 11,902 loyal patients, 75% made
visits toward one or two specialties and otherwise. Themedical expenditures, OPD
visits, ED visits reduced 2.4%, 4.8% and 6.3% per person permonth,respectively, but
the number of Rx increased 0.2%. The differences of the health resources utiliza-
tion were reduced from the first to fourth quarter of implementation period.
CONCLUSIONS: There were positive outcomes of offering pluralistic IMC services.
However, the outcomes would be more significant across time if the IMC services
were emphasized more toward those who visited more than three specialists.
Health Care Use & Policy Studies – Health Technology Assessment Programs
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OBJECTIVES: Frequently, technology appraisal decisions are based on the ICERs
estimated from economic models. The study objective was to investigate reasons
provided by three Health Technology Assessment authorities for acceptance of
high ICER submissions (commonly assumed threshold above £30,000) and rejection
of low ICER submissions (commonly assumed threshold below £30,000).
METHODS: All published technology appraisals since April 2005 were downloaded
from PBAC, SMC, and CADTH, websites. The manufacturer’s base-case ICERs were
extracted. Decision drivers provided by the agencies were extracted from the tech-
nology appraisals which were rejected despite a low ICER or accepted despite a
high ICER. RESULTS: The CADTH accepted 14 high ICER submissions; 71% owing to
stated clinical effectiveness, including 42% on the basis of restriction and 15%
restricted duration. The PBAC accepted 26 high ICER submissions; 53% owing to
stated cost-effectiveness, 30% with restriction, and 19% with a risk sharing agree-
ment. The SMC accepted 22 high ICER submissions; 68% owing to restriction, and
31% owing to orphan drug status. The CADTH rejected 2 low ICER submissions
owing to a lack of demonstrated clinical benefit. PBAC rejected 48 low ICER sub-
missions; 73% owing to lack of demonstrated clinical benefit, 40% owing to uncer-
tainty in the economic model, and and 27% owing to an unacceptably high ICER.
The SMC rejected 62 low ICER submissions; 34% owing to a lack of demonstrated
clinical efficacy, 71% owing to lack of a robust economic analysis, and 31% owing to
cost-effectiveness not being demonstrated. CONCLUSIONS: Aside from a demon-
stration of clinical and / or cost-effectiveness, high ICERs were accepted on the
basis of a restriction to certain patient groups, price reduction, or owing to orphan
drug status. Low ICER submissions were rejected on the basis of uncertain or lack-
ing clinical benefit, uncertain model estimates, or a lack of appropriate analysis.
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AHRQ VERSUS NICE: DO THE CONCLUSIONS IN CER REPORTS CORRESPOND
CLOSELY TO THE COMPARATIVE EFFECTIVENESS ASSESSMENTS MADE IN HTA
REPORTS?
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HERON Evidence Development Ltd, London, UK
OBJECTIVES: While non-US agencies such as NICE (National Institute for Health
and Clinical Excellence) in the UK have been conducting Health Technology As-
sessments (HTAs) for over ten years, Comparative Effectiveness Research (CER) as
conducted in the US is relatively recent. The lack of economic considerations is one
well-defined distinction between CER and HTA. The aim of this research is to
compare CER publications from AHRQ (Agency for Healthcare Research and Qual-
ity) with HTA-related publications fromNICE to determinewhether there are other
consistent, clear distinctions of note. METHODS: All 22 AHRQ CER publications
published on the National Institutes of Health website were assessed. Conclusions
relating to the comparative effectiveness of pharmaceuticals onmajor clinical out-
comes were compiled. The NICE website was searched for corresponding HTA
guidance, and conclusions and other features of the publications were compared.
RESULTS:Of the 14AHRQCERpublications that assessed pharmaceuticals, for only
two of these were there corresponding NICE HTAs. The CER publication on Rheu-
matoid Arthritis and Psoriatic Arthritis corresponded to two NICE HTAs, which
were both in general agreement with the CER report. In contrast, the conclusion
from the CER publication on Lipid-Modifying Agents stated that there was insuffi-
cient clinical evidence to guide decisions, whereas NICE was confident enough in
the evidence to make a subsequent access decision. In its Clinical Guideline (CG)
documentsNICE also provided statements relevant to three other AHRQCER report
topics; all were in general agreement with the AHRQ CER conclusions. The most
notable distinctions between CER and HTA reports, however, were in their scope,
breadth, and purpose. CONCLUSIONS:Where like-for-like comparisons were pos-
sible, this research found more agreement than disagreement between AHRQ and
NICE. Themajor distinctions of note related to the topics chosen for assessment by
the two agencies, which reflect differences in priorities between health systems.
PHP85
APPLYING FUZZY MULTIPLE CRITERIA DECISION MAKING TO ESTABLISH A
NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM WITH COVERAGE
IMPLICATIONS IN TAIWAN NATIONAL HEALTH INSURANCE
Lin CW
I-Shou University, Kaohsiung, Taiwan
OBJECTIVES: It became obvious that all countries consider health technology as-
sessment (HTA) differently due to the structure of individual health systems. The
objective of this study was to select and establish a new, proper HTA system in
Taiwan National Health Insurance.METHODS: A systematic literature review was
undertaken to identify relevant papers of each of short tandem polymorphism
analysis, positron emission tomography, photodynamic laser therapy and video-
assisted thoracic surgery and then used focus group discussion to select category’s
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